SiRNA RSS Page 4

Filtered By:
Cancer: HER2

Filter By:
Specialty
Source
Condition
Cancer
Infectious Disease
Drug
Training
Management
Procedure
Therapy
Vaccine
Nutrition
Country

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 260 results found since Jan 2013.

Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy
Conclusion: The current investigation focuses on designing a multifunctional drug delivery platform for concurrent delivery of either PAC or PARP inhibitor (olaparib) and FOXM1 siRNA in chitosan-coated poly(D, L-lactide-co-glycolide) (PLGA) nanoparticles (NPs) with the ability to emerge as a front runner therapeutic for TNBC therapy.PMID:34336608 | PMC:PMC8314031 | DOI:10.34172/bi.2021.27
Source: BioImpacts - August 2, 2021 Category: Research Authors: Ranjita Misra Bamadeb Patra Sudha Varadharaj Rama Shanker Verma Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18